Expanding Diagnostic Portfolio BÜHLMANN's recent launches of turbo assays and collaborations with QuidelOrtho to integrate their calprotectin tests on VITROS systems demonstrate a growing product line and increased market reach, presenting opportunities to upsell complementary diagnostic solutions to existing clients.

Global Market Presence With local teams in multiple countries including Switzerland, France, Italy, Germany, Austria, the USA, and Brazil, BÜHLMANN has strong regional footholds, enabling sales development efforts to focus on expanding their customer base across these key markets especially within Europe and North America.

Innovative Test Offerings BÜHLMANN's focus on unique assays such as calprotectin, Basophil Activation Testing, and anti-ganglioside ELISAs allows for targeted sales strategies aimed at specialized clinics and laboratories seeking high-quality, assay-specific solutions.

Partnership Driven Growth Strategic partnerships with companies like Telia and Seegene, along with collaborations on assay development, highlight an openness to joint ventures and co-marketing opportunities that can be leveraged to expand their distribution channels and penetrate new customer segments.

Digital and Home Testing BÜHLMANN's remote diagnostics offerings, such as the IBDoc home test, present untapped sales potential in telemedicine and remote patient management markets, particularly as healthcare providers increasingly adopt decentralized testing solutions.